Literature DB >> 12535753

Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes.

Eeva Leinonen1, Eva Hurt-Camejo, Olov Wiklund, Lillemor Mattson Hultén, Anne Hiukka, Marja-Riitta Taskinen.   

Abstract

OBJECTIVE: To investigate the relationship of inflammation and endothelial activation with insulin resistance and adiposity in type 2 diabetes. METHODS AND
RESULTS: Hundred and thirty-four (45 female) type 2 diabetic subjects aged 50-75 in the Fenofibrate Intervention and Event Lowering in Diabetes Study in Helsinki were examined before fenofibrate intervention. Fasting levels of circulating intercellular cell adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) (vascular cell adhesion molecule), ultra-sensitive C-reactive protein (CRP), human serum amyloid A (hSAA), interleukin-6 (IL-6), macrophage colony-stimulating factor (M-CSF), secretory phospholipase A(2) IIA (PLA(2)), total, HDL and LDL cholesterol, triglycerides, P-glucose, HbA1c, and serum free insulin were determined. Insulin resistance was assessed by the homeostasis model. HOMA IR correlated significantly with all measures of adiposity and markers of inflammation and endothelial dysfunction. BMI was significantly associated with inflammation and endothelial activation, but with neither lipoproteins nor glycaemic control. After controlling for age, gender and BMI, HbA1c correlated significantly with CRP, hSAA, ICAM-1, E-selectin, and HOMA IR. HDL cholesterol correlated inversely with IL-6, M-CSF, E-selectin, and HOMA IR. HbA1c, phospholipase A(2), VCAM-1, and HDL cholesterol remained independent determinants of HOMA IR in the linear regression analysis controlled for age, gender, and BMI.
CONCLUSION: Endothelial activation and acute-phase reaction correlate with insulin resistance and obesity in type 2 diabetic patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12535753     DOI: 10.1016/s0021-9150(02)00371-4

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  64 in total

Review 1.  The vagus nerve and the inflammatory reflex--linking immunity and metabolism.

Authors:  Valentin A Pavlov; Kevin J Tracey
Journal:  Nat Rev Endocrinol       Date:  2012-12       Impact factor: 43.330

2.  Serum amyloid A: production by human white adipocyte and regulation by obesity and nutrition.

Authors:  C Poitou; N Viguerie; R Cancello; R De Matteis; S Cinti; V Stich; C Coussieu; E Gauthier; M Courtine; J D Zucker; G S Barsh; W Saris; P Bruneval; A Basdevant; D Langin; K Clément
Journal:  Diabetologia       Date:  2005-02-24       Impact factor: 10.122

3.  The release of soluble VAP-1/SSAO by 3T3-L1 adipocytes is stimulated by isoproterenol and low concentrations of TNFalpha.

Authors:  S García-Vicente; A Abella; N Viguerie; A Ros-Baró; M Camps; X Testar; M Palacín; A Zorzano; L Marti
Journal:  J Physiol Biochem       Date:  2005-06       Impact factor: 4.158

4.  Deficiency of Endogenous Acute-Phase Serum Amyloid A Protects apoE-/- Mice From Angiotensin II-Induced Abdominal Aortic Aneurysm Formation.

Authors:  Nancy R Webb; Maria C De Beer; Joanne M Wroblewski; Ailing Ji; William Bailey; Preetha Shridas; Richard J Charnigo; Victoria P Noffsinger; Jassir Witta; Deborah A Howatt; Anju Balakrishnan; Debra L Rateri; Alan Daugherty; Frederick C De Beer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-03-05       Impact factor: 8.311

Review 5.  Association between serum amyloid A and obesity: a meta-analysis and systematic review.

Authors:  Yulan Zhao; Xuelian He; Xuegui Shi; Chengjin Huang; Jie Liu; Shuli Zhou; Chew-Kiat Heng
Journal:  Inflamm Res       Date:  2010-02-07       Impact factor: 4.575

Review 6.  The evolving role of inflammation in obesity and the metabolic syndrome.

Authors:  Yong-Ho Lee; Richard E Pratley
Journal:  Curr Diab Rep       Date:  2005-02       Impact factor: 4.810

7.  Serum amyloid A3 does not contribute to circulating SAA levels.

Authors:  Tsuyoshi Chiba; Chang Yeop Han; Tomas Vaisar; Kentaro Shimokado; Atil Kargi; Mei-Hsiu Chen; Shari Wang; Thomas O McDonald; Kevin D O'Brien; Jay W Heinecke; Alan Chait
Journal:  J Lipid Res       Date:  2009-03-12       Impact factor: 5.922

8.  A randomized phase II dose-response exercise trial among colon cancer survivors: Purpose, study design, methods, and recruitment results.

Authors:  Justin C Brown; Andrea B Troxel; Bonnie Ky; Nevena Damjanov; Babette S Zemel; Michael R Rickels; Andrew D Rhim; Anil K Rustgi; Kerry S Courneya; Kathryn H Schmitz
Journal:  Contemp Clin Trials       Date:  2016-03-10       Impact factor: 2.226

Review 9.  Anatomy of coronary disease in diabetic patients: an explanation for poorer outcomes after percutaneous coronary intervention and potential target for intervention.

Authors:  K P Morgan; A Kapur; K J Beatt
Journal:  Heart       Date:  2004-07       Impact factor: 5.994

10.  DPP-4 (CD26) inhibitor sitagliptin exerts anti-inflammatory effects on rat insulinoma (RINm) cells via suppressing NF-κB activation.

Authors:  Xingyun Hu; Shanying Liu; Xiaodan Liu; Jinglu Zhang; Ying Liang; Yan Li
Journal:  Endocrine       Date:  2016-09-09       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.